Department of Otolaryngology, Charles Drew University of Medicine and Science, Los Angeles, California 90059, USA.
J Radiat Res. 2013 May;54(3):419-29. doi: 10.1093/jrr/rrs119. Epub 2013 Jan 3.
The aim of the current study is to examine the protective effect of MGN-3 on overall maintenance of hematopoietic tissue after γ-irradiation. MGN-3 is an arabinoxylan from rice bran that has been shown to be a powerful antioxidant and immune modulator. Swiss albino mice were treated with MGN-3 prior to irradiation and continued to receive MGN-3 for 1 or 4 weeks. Results were compared with mice that received radiation (5 Gy γ rays) only, MGN-3 (40 mg/kg) only and control mice (receiving neither radiation nor MGN-3). At 1 and 4 weeks post-irradiation, different hematological, histopathological and biochemical parameters were examined. Mice exposed to irradiation alone showed significant depression in their complete blood count (CBC) except for neutrophilia. Additionally, histopathological studies showed hypocellularity of their bone marrow, as well as a remarkable decrease in splenic weight/relative size and in number of megakaryocytes. In contrast, pre-treatment with MGN-3 resulted in protection against irradiation-induced damage to the CBC parameters associated with complete bone marrow cellularity, as well as protection of the aforementioned splenic changes. Furthermore, MGN-3 exerted antioxidative activity in whole-body irradiated mice, and provided protection from irradiation-induced loss of body and organ weight. In conclusion, MGN-3 has the potential to protect progenitor cells in the bone marrow, which suggests the possible use of MGN-3/Biobran as an adjuvant treatment to counteract the severe adverse side effects associated with radiation therapy.
本研究旨在探讨 MGN-3 对 γ 射线照射后造血组织整体维持的保护作用。MGN-3 是一种来自米糠的阿拉伯木聚糖,已被证明具有强大的抗氧化和免疫调节作用。瑞士白化病小鼠在照射前用 MGN-3 治疗,并继续接受 MGN-3 治疗 1 或 4 周。结果与仅接受辐射(5 Gy γ 射线)、仅接受 MGN-3(40 mg/kg)和未接受辐射和 MGN-3 的对照小鼠进行比较。在照射后 1 周和 4 周时,检查了不同的血液学、组织病理学和生化参数。单独暴露于照射下的小鼠的全血细胞计数(CBC)明显下降,除了中性粒细胞增多症。此外,组织病理学研究表明骨髓细胞减少,脾重/相对大小和巨核细胞数量明显减少。相比之下,MGN-3 的预先治疗导致与骨髓细胞完全性相关的 CBC 参数免受照射诱导的损伤,并且保护上述脾变化。此外,MGN-3 在全身照射的小鼠中发挥抗氧化活性,并防止照射引起的体重和器官重量损失。总之,MGN-3 有可能保护骨髓中的祖细胞,这表明 MGN-3/Biobran 可能作为辅助治疗用于抵消与放射治疗相关的严重不良反应。